Why Are We Still Talking About Hydroxychloroquine as a Treatment for COVID-19? episode artwork

EPISODE · Aug 13, 2020 · 13 MIN

Why Are We Still Talking About Hydroxychloroquine as a Treatment for COVID-19?

from JAMA Clinical Reviews

The use of hydroxychloroquine as a treatment for COVID-19 serves as an example of what is wrong with medical information being widely disseminated before it is thoroughly vetted by peer review. Preliminary studies of this treatment modality were spread widely, creating false hope that a treatment for COVID-19 existed. Several randomized trials have shown that hydroxychloroquine is not an effective therapy for COVID-19. David Juurlink, MD, PhD, from the University of Toronto summarizes the evidence base regarding hydroxychloroquine and COVID-19. Related Article(s): Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

Episode metadata supplied by the publisher feed · Published Aug 13, 2020

Embed this episode

NOW PLAYING

Why Are We Still Talking About Hydroxychloroquine as a Treatment for COVID-19?

0:00 13:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Clinical Reviews?

This episode is 13 minutes long.

When was this JAMA Clinical Reviews episode published?

This episode was published on August 13, 2020.

Can I download this JAMA Clinical Reviews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!